← All stocks

OKYO Pharma Ltd

OKYO No buying or selling

CIK 0001849296 #4479 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

6 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

CERRONE GABRIELE M

Director

—

10,873,916

20.72%

$16.31M

+3.3%

JACOB GARY S

CHIEF DEVELOPMENT OFFICER

—

112,420

0.2142%

$168.63K

+3.2%

BRANCACCIO JOHN P

Director

—

35,201

0.0671%

$52.80K

+16.6%

Patil Rajkumar V.

Chief Scientific Officer

—

20,030

0.0382%

$30.05K

+20.2%

Mantelli Flavio

CHIEF MEDICAL OFFICER

—

20,000

0.0381%

$30.00K

—

Dempsey Robert John

CHIEF EXECUTIVE OFFICER

—

15,000

0.0286%

$22.50K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12

Amendments (4/A) skipped 7

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 394,363

History held since 18 May 2022